Opinion | March 24, 2022
Clinical Trials in the New Normal
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
Machine learning approach to systems biology combined with ligand discovery platform
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
12-week certificate course commences on March 10th 2022
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis
Dr. Peter Houghton will lead the research collaboration for GCCRI and is widely regarded as a leading expert in pediatric cancer research and in the development of novel approaches to treating childhood cancers
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
Subscribe To Our Newsletter & Stay Updated
